Results 231 to 240 of about 1,001,494 (307)

Water-Tolerant Iminium Reactive Species for Tyrosine-Specific Functionalization. [PDF]

JACS Au
Mondal B, Wang L, Wang S, Loh TP.
europepmc   +1 more source

Regulation and activity of the phosphatase SHP2: SH2 domains, dephosphorylation activity, and beyond. [PDF]

Biochem Soc Trans
Pierotti CL, Köhn M.
europepmc   +1 more source

Critical role of the CMGC insert sequence for tyrosine autophosphorylation in the protein kinase DYRK1B. [PDF]

Sci Rep
Detro-Dassen S, Schwandt K, Helmich P, Düsterhöft S, Becker W.   +4 more
europepmc   +1 more source

ERRATUM: Value of soluble fms-like tyrosine kinase 1 for predicting acute pancreatitis severity: a systematic review and meta-analysis. [PDF]

Rev Assoc Med Bras (1992)
europepmc   +1 more source

Efficacy and Safety of Human Epidermal Growth Factor Receptor 2 (HER2) Antibody-Drug Conjugates in Solid Tumors Harboring Non-tyrosine Kinase Domain ERBB2 Mutations: A Systematic Review. [PDF]

Cureus
Ohta R, Fujimori T, Tanaka K, Hayashi H.
europepmc   +1 more source

Plasma enhanced vapor deposition of dipeptide nanostructures: nanotubes to nanoflowers.

Mater Adv
Pagliuca J, Macha P, Naeem M, Vasudev MC.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Lancet, The, 2005
Linda M Scott, George S Vassiliou, Anthony R Green   +2 more
exaly   +2 more sources

Protein tyrosine phosphatases: from genes, to function, to disease

Nature Reviews Molecular Cell Biology, 2006
N. Tonks
exaly   +2 more sources

Tyrosine O‐Sulfation

Current Protocols in Protein Science, 2005
AbstractThe O‐sulfation of tyrosine residues of plasma membrane and secretory proteins that transit through the secretory pathway of eukaryotic cells is a widespread post‐translational modification. This enzymatic reaction is catalyzed by trans‐Golgi‐associated tyrosylprotein sulfotransferases, which recognize tyrosine residues located in a specific ...
Corbeil, D., Thiele, C., Huttner, W.
openaire   +3 more sources

Tyrosine Kinase Inhibitors

Current Cancer Drug Targets, 2010
Over the last ten years, several new and therapeutically relevant cancer drugs targeting tyrosine kinases signaling pathways have been developed. Tyrosine kinase inhibitors (TKIs) are a pharmaceutical class of small molecules, orally available, well-tolerated, worldwide approved drugs for the treatment of several neoplasms, including lung, breast ...
NATOLI, Clara, Perrucci Bruno, Perrotti Francesca, Falchi Lorenzo, IACOBELLI, Stefano, Consorzio Interuniversitario Nazionale per Bio Oncologia   +5 more
openaire   +3 more sources